Eupraxia Pharmaceuticals (EPRX)announced that it has appointed Alex Rothwell as the Company’s new Chief Financial Officer, effective immediately. Bruce Cousins, the Company’s outgoing CFO, is retiring and will remain in a consultant role in the near-term to ensure an orderly transition of the CFO responsibilities.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.